Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -464.02 |
peg ratio | 11.95 |
price to book ratio | -11,035.52 |
price to sales ratio | 14.62 |
enterprise value multiple | 289.53 |
price fair value | -11,035.52 |
profitability ratios | |
---|---|
gross profit margin | 87.0% |
operating profit margin | 4.38% |
pretax profit margin | -2.63% |
net profit margin | -3.11% |
return on assets | -1.82% |
return on equity | 47.92% |
return on capital employed | 3.47% |
liquidity ratio | |
---|---|
current ratio | 3.01 |
quick ratio | 2.93 |
cash ratio | 0.92 |
efficiency ratio | |
---|---|
days of inventory outstanding | 100.56 |
operating cycle | 148.75 |
days of payables outstanding | 88.59 |
cash conversion cycle | 60.16 |
receivables turnover | 7.58 |
payables turnover | 4.12 |
inventory turnover | 3.63 |
debt and solvency ratios | |
---|---|
debt ratio | 0.62 |
debt equity ratio | -804.98 |
long term debt to capitalization | 1.00 |
total debt to capitalization | 1.00 |
interest coverage | 0.79 |
cash flow to debt ratio | 0.15 |
cash flow ratios | |
---|---|
free cash flow per share | 2.52 |
cash per share | 20.71 |
operating cash flow per share | 2.94 |
free cash flow operating cash flow ratio | 0.86 |
cash flow coverage ratios | 0.15 |
short term coverage ratios | 3.59 |
capital expenditure coverage ratio | 6.97 |
Frequently Asked Questions
Alnylam Pharmaceuticals, Inc. (ALNY) published its most recent earnings results on 01-08-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)'s trailing twelve months ROE is 47.92%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Alnylam Pharmaceuticals, Inc. (ALNY) currently has a ROA of -1.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
ALNY reported a profit margin of -3.11% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.01 in the most recent quarter. The quick ratio stood at 2.93, with a Debt/Eq ratio of -804.98.